SE7600729L - PROSTAGLAND INFORMATIONS - Google Patents

PROSTAGLAND INFORMATIONS

Info

Publication number
SE7600729L
SE7600729L SE7600729A SE7600729A SE7600729L SE 7600729 L SE7600729 L SE 7600729L SE 7600729 A SE7600729 A SE 7600729A SE 7600729 A SE7600729 A SE 7600729A SE 7600729 L SE7600729 L SE 7600729L
Authority
SE
Sweden
Prior art keywords
methyl
hydrogen
symbol
carbon atoms
alkyl
Prior art date
Application number
SE7600729A
Other languages
Swedish (sv)
Other versions
SE446726B (en
Inventor
U Guzzi
R Ciabatti
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of SE7600729L publication Critical patent/SE7600729L/en
Publication of SE446726B publication Critical patent/SE446726B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Novel prostaglandin analogues of the general formula: (I) wherein the ring P represents one of the groups: (a) (b) (c) the symbol A represents -CH2-CH2 - or cis-CH=CH-; the symbol B represents-CH2 -CH2 - or trans-CH=CH-; R is hydrogen, alkyl of 1 to 6 carbon atoms, or a cation; R1 is alkyl of 1 to 6 carbon atoms, R2 represents a straight chain alkyl radical selected from methyl, ethyl, propyl, butyl, pentyl and hexyl; R3 is hydrogen or methyl; R4 is hydrogen or methyl; and R5 is hydroxy or R4 and R5 taken together represent an oxo group are disclosed, together with processes for their preparation. The new compounds have luteolytic, antihypertensive, bronchodilating and anti secretory activity.
SE7600729A 1975-01-24 1976-01-23 PROCEDURE FOR THE PREPARATION OF 16-METOXIPROSTAGLANDINES SE446726B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3248/75A GB1538871A (en) 1975-01-24 1975-01-24 Prostaglandins

Publications (2)

Publication Number Publication Date
SE7600729L true SE7600729L (en) 1976-07-25
SE446726B SE446726B (en) 1986-10-06

Family

ID=9754749

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7600729A SE446726B (en) 1975-01-24 1976-01-23 PROCEDURE FOR THE PREPARATION OF 16-METOXIPROSTAGLANDINES

Country Status (28)

Country Link
JP (1) JPS6024098B2 (en)
AR (1) AR212328A1 (en)
AT (1) AT351186B (en)
BE (1) BE837865A (en)
CA (1) CA1076569A (en)
CH (1) CH609682A5 (en)
CS (1) CS187333B2 (en)
DD (1) DD122517A5 (en)
DE (1) DE2601646A1 (en)
DK (1) DK27376A (en)
FI (1) FI64578C (en)
FR (1) FR2298322A1 (en)
GB (1) GB1538871A (en)
GR (1) GR58537B (en)
HU (1) HU174185B (en)
IE (1) IE43821B1 (en)
IL (1) IL48870A (en)
LU (1) LU74240A1 (en)
NL (1) NL185203C (en)
NO (1) NO147714C (en)
NZ (1) NZ179816A (en)
PH (1) PH14040A (en)
PT (1) PT64737B (en)
RO (1) RO71901A (en)
SE (1) SE446726B (en)
SU (1) SU607550A3 (en)
YU (1) YU40805B (en)
ZA (1) ZA7681B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064350A (en) * 1976-11-22 1977-12-20 G. D. Searle & Co. 15,16-Dihydroxyprostaglandins
US4194055A (en) * 1976-03-03 1980-03-18 American Cyanamid Company 15,16-dioxy prostenoic acids and esters
IT1162731B (en) * 1979-04-10 1987-04-01 Lepetit Spa 16-METHYL-16-METHOXY-5,6-DIHYDRO-PROSTA-GLANDINE OF THE E1 SERIES WITH ANTI-SECRETORY ACTIVITY
JPS56162014A (en) * 1980-05-16 1981-12-12 Nippon Denso Co Ltd Measuring device for flow rate of gas

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1392716A (en) * 1971-05-11 1975-04-30 Ici Ltd Moulding
US4304907A (en) * 1972-05-10 1981-12-08 The Upjohn Company Bicyclo lactone intermediates for prostaglandin analogs

Also Published As

Publication number Publication date
GB1538871A (en) 1979-01-24
AR212328A1 (en) 1978-06-30
IE43821B1 (en) 1981-06-03
RO71901A (en) 1982-02-26
ZA7681B (en) 1976-12-29
DK27376A (en) 1976-07-25
YU40805B (en) 1986-06-30
DD122517A5 (en) 1976-10-12
IE43821L (en) 1976-07-24
FR2298322B1 (en) 1979-09-21
GR58537B (en) 1977-10-31
CA1076569A (en) 1980-04-29
YU11176A (en) 1982-10-31
DE2601646A1 (en) 1976-07-29
FR2298322A1 (en) 1976-08-20
JPS5198249A (en) 1976-08-30
SE446726B (en) 1986-10-06
NO147714C (en) 1983-06-01
FI64578B (en) 1983-08-31
NZ179816A (en) 1978-04-03
DE2601646C2 (en) 1987-07-02
JPS6024098B2 (en) 1985-06-11
NL7600696A (en) 1976-07-27
PT64737B (en) 1977-08-12
IL48870A0 (en) 1976-03-31
SU607550A3 (en) 1978-05-15
LU74240A1 (en) 1976-07-23
PH14040A (en) 1980-12-12
FI64578C (en) 1983-12-12
IL48870A (en) 1979-11-30
NO147714B (en) 1983-02-21
PT64737A (en) 1976-02-01
BE837865A (en) 1976-07-23
CS187333B2 (en) 1979-01-31
HU174185B (en) 1979-11-28
AT351186B (en) 1979-07-10
FI760002A (en) 1976-07-25
CH609682A5 (en) 1979-03-15
NL185203B (en) 1989-09-18
ATA36776A (en) 1978-12-15
NO760214L (en) 1976-07-27
NL185203C (en) 1990-02-16

Similar Documents

Publication Publication Date Title
US4110381A (en) 2-Decarboxy-2-hydroxy-methyl-3,7-inter-m-phenylene-ω-phenoxy-PGF.sub.1
GB1409843A (en) Prostaglandin intermediates
GB1519433A (en) Detergent composition
US4097506A (en) Cis-13,9-deoxy-PGF1 compounds
SE7600729L (en) PROSTAGLAND INFORMATIONS
DE3372095D1 (en) Novel phenylpiperazine derivatives and process for producing the same
GB1453570A (en) Oxazolidine derivatives
GB1506816A (en) Prostaglandins
DK122085D0 (en) INTERMEDIATES FOR THE PREPARATION OF ANALYSIS OF PROSTAGLANDIN
GB1240087A (en) N(6)-alkyl-adenosine derivatives
GB1449147A (en) Prostaglandin intermediates method for electro coating metal surfaces with carbon
IE42941L (en) Furo-furones
ES471267A1 (en) Lower alkyl 2-tri-(lower)alkylsilylacetylene-N-carbethoxyglycinates and process for using same
GB1305547A (en)
US4242268A (en) Bicyclic lactones
ES444566A1 (en) Procedure for preparing prostaglandine analogues. (Machine-translation by Google Translate, not legally binding)
ES456912A1 (en) 5(6)-benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
GB1436832A (en) Prostaglandin intermediates and their preparation
ES502668A0 (en) PROCEDURE FOR PREPARING A HYDROCARBON SOLUTION OF AN ALKYL SODIUM COMPOUND
ES428047A1 (en) 4,5,10,13 prostatetraenoic acid derivatives
US4366313A (en) 2-Decarboxy-2-tetrazolyl-6-keto-PGE1 compounds
US4164501A (en) 2-Decarboxy-2-hydroxymethyl-trans-4,5,13,14-tetradehydro-PGI1 compounds
ES394667A1 (en) Preparation of prostanoic acid derivatives
GB1432736A (en) Substituted 2-pyrones and process for their preparation
ES460608A1 (en) Novel prostaglandin derivatives

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7600729-3

Effective date: 19930810

Format of ref document f/p: F